THE EFFECT OF A NEW ANTIRHEUMATIC DRUG, TRIETHYLPHOSPHINE GOLD (AURANOFIN), ON IN VITRO LYMPHOCYTE AND MONOCYTE CYTOTOXICITYRUSSELL AS; DAVIS P; MILLER C et al.1982; JOURNAL OF RHEUMATOLOGY; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; NO 1; PP. 30-35; BIBL. 14 REF.Article

L'Auranofine améliore le devenir des malades atteints de polyarthrite rhumatoïde débutante: résultats à 2 ans d'une étude contrôlée en double aveugle contre placebo = Auranofin improves out come in early rheumatoid arthritis. Results from a 2 years double blind. Placebo controlled studyBORG, G; ALLANDER, E; LUND, B et al.Rhumatologie (Aix-les-Bains). 1989, Vol 41, Num 8, pp 247-257, issn 0249-7581, 11 p.Article

Jessner's lymphocytic infiltrate responding to oral auranofinHAFEJEE, A; WINHOVEN, S; COULSON, I. H et al.Journal of dermatological treatment. 2004, Vol 15, Num 5, pp 331-332, issn 0954-6634, 2 p.Article

Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitroKIM, I. S; JIN, J. Y; LEE, I. H et al.British journal of pharmacology. 2004, Vol 142, Num 4, pp 749-755, issn 0007-1188, 7 p.Article

Arsenic trioxide and auranofin inhibit selenoprotein synthesis : implications for chemotherapy for acute promyelocytic leukaemiaTALBOT, S; NELSON, R; SELF, W. T et al.British journal of pharmacology. 2008, Vol 154, Num 5, pp 940-948, issn 0007-1188, 9 p.Article

Auranofin promotes retinoic acid-or dihydroxyvitamin D₃-mediated cell differentiation of promyelocytic leukaemia cells by increasing histone acetylationPARK, S. J; KIM, M; KIM, N. H et al.British journal of pharmacology. 2008, Vol 154, Num 6, pp 1196-1205, issn 0007-1188, 10 p.Article

Effect of a gold-chloroquine complex on inflammation-related leukocyte functions and cell viability : Comparison with auranofinNAVARRO, Maribel; FRAILE, German; VELASQUEZ, Mait et al.Arzneimittel-Forschung. 2006, Vol 56, Num 12, pp 826-833, issn 0004-4172, 8 p.Article

MODULATION OF NEUTROPHIL FUNCTIONS BY AURANOFIN. STUDIES ON EFFECTS IN VITRO AND IN RHEUMATOID ARTHRITIS PATIENTSHAFSTROEM I; UDEN AM; PALMBLAD J et al.1983; SCANDINAVIAN JOURNAL OF RHEUMATOLOGY; ISSN 0300-9742; SWE; DA. 1983; VOL. 12; NO 2; PP. 97-105; BIBL. 27 REF.Article

PHARMAKOLOGISCHE FRAGEN DES KLINIKERS AN AURANOFIN = QUESTIONS PHARMACOLOGIQUES DU CLINICIEN SUR L'AURANOFINMENNINGER H; BURKHARDT H.1983; AKTUELLE RHEUMATOLOGIE; ISSN 0341-051X; DEU; DA. 1983; VOL. 8; SUPPL. 1; PP. 9-13; ABS. ENG; BIBL. 30 REF.Article

THERAPEUTIC INNOVATION IN RHEUMATOID ARTHRITIS. WORLDWIDE AURANOFIN SYMPOSIUM, MONTREAL, CANADA, OCTOBER 20-21, 1981DAVIS P ED; HARTH M ED.1982; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; SUPPL. NO 8; 209 P.; BIBL. DISSEM.Conference Paper

A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lambliaTEJMAN-YARDEN, Noa; MIYAMOTO, Yukiko; LEITSCH, David et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 5, pp 2029-2035, issn 0066-4804, 7 p.Article

Cellular and molecular pharmacology of auranofin and related gold complexesCROOKE, S. T; SNYDER, R. M; BUTT, T. R et al.Biochemical pharmacology. 1986, Vol 35, Num 20, pp 3423-3431, issn 0006-2952Article

Gold levels produced by treatment with auranofin and sodium aurothiomalateLEWIS, D; CAPELL, H. A; MCNEIL, C. J et al.Annals of the rheumatic diseases. 1983, Vol 42, Num 5, pp 566-570, issn 0003-4967Article

Proceedings/Ridaura (auranofin): 1986, a Smith Kline and French international symposium, Amsterdam 21 June 1986DAVIS, T. G.Scandinavian journal of rheumatology. Supplement. 1986, issn 0301-3847, 95 p., suppl. 63Conference Proceedings

Oral gold therapy in rheumatoid arthritis: auranofin, symposium, San Francisco CA, August 3 and 4, 1982BLECHMAN, W. J; GOTTLIEB, N. L.The American journal of medicine. 1983, Vol 75, Num 6, issn 0002-9343, 164 p.Conference Proceedings

Reactions of the metallodrug auranofin [(1-thio-β-D-glucopyranose-2,3,4,6-tetraacetato-S)(triethylphosphine)gold] with biological ligands studied by radioisotope methodologyECKER, D. J; HEMPEL, J. C; SUTTON, B. M et al.Inorganic chemistry (Print). 1986, Vol 25, Num 18, pp 3139-3143, issn 0020-1669Article

Acquired resistance to auranofin in cultured human cellsGLENNAS, A; RUGSTAD, H. E.Scandinavian journal of rheumatology. 1985, Vol 14, Num 3, pp 230-238, issn 0300-9742Article

Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin: a comparison of different methods of determinationVAN RIEL, P. L. C. M; GRIBNAU, F. W. J; VAN DE PUTTE, L. B. A et al.Journal of rheumatology. 1983, Vol 10, Num 4, pp 574-578, issn 0315-162XArticle

Titanate particles as agents to deliver gold compounds to fibroblasts and monocytesDAVIS, Ryan R; HOBBS, David T; KHASHABA, Rania et al.Journal of biomedical materials research. Part A. 2010, Vol 93, Num 3, pp 864-869, issn 1549-3296, 6 p.Article

The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cellsPARK, Seon-Joo; KIM, In-Sook.British journal of pharmacology. 2005, Vol 146, Num 4, pp 506-513, issn 0007-1188, 8 p.Article

THE EFFECT OF AURANOFIN AND SODIUM AUROTHIOMALATE ON PERIPHERAL BLOOD MONOCYTESSCHEINBERG MA; SANTOS LMB; FINKELSTEIN AE et al.1982; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; NO 3; PP. 366-369; BIBL. 20 REF.Article

IMMUNOPHARMACOLOGY OF GOLD SODIUM THIOMALATE AND AURANOFIN (SK & F D-39162)WALZ DT; GRISWOLD DE.1978; INFLAMMATION; USA; DA. 1978; VOL. 3; NO 2; PP. 117-128; BIBL. 38 REF.Article

An open study of auranofin in the treatment of steroid-dependent asthmaBERNSTEIN, D. I; BERNSTEIN, I. L; BODENHEIMER, S. S et al.Journal of allergy and clinical immunology. 1988, Vol 81, Num 1, pp 6-16, issn 0091-6749Article

Effects of auranofin and other antirheumatic drugs on human myelopoiesis in vitroHAMILTON, J. A; WILLIAMS, N.Journal of rheumatology. 1987, Vol 14, Num 2, pp 216-220, issn 0315-162XArticle

Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrplb InflammasomeNEWMAN, Zachary L; SIRIANNI, Nicole; MAWHINNEY, Christina et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 3, pp 1028-1035, issn 0066-4804, 8 p.Article